Skip to content
← Acute Lymphoblastic Leukemia

FOR PATIENTS · SOURCE READING

Immunotherapy

Source: Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview / The following types of treatment are used:

Immunotherapy helps a person's immune system fight cancer. Your doctor may suggest biomarker tests to help predict your response to certain immunotherapy drugs. Learn more about Biomarker Testing for Cancer Treatment.

Source links and citations

Immunotherapies used to treat ALL include:

blinatumomab

Source links and citations

inotuzumab ozogamicin

Source links and citations

CAR T-cell therapy with brexucabtagene autoleucel or tisagenlecleucel

Source links and citations

Learn more about Immunotherapy to Treat Cancer.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice